Quarterly ResultMay 8, 2026, 06:13 AM
Astrana Health Q1 Revenue +55.6% to $965.1M; EPS $0.29
AI Summary
Astrana Health reported strong financial results for the first quarter of 2026. The company's total revenue increased significantly by 55.6% to $965.1 million, while net income attributable to Astrana Health, Inc. more than doubled to $14.4 million. Diluted earnings per share also saw substantial growth, rising to $0.29, and net cash provided by operating activities surged by over 300%.
Key Highlights
- Total revenue increased by 55.6% to $965.1 million for Q1 2026, up from $620.4 million in Q1 2025.
- Net income attributable to Astrana Health, Inc. rose 115.7% to $14.4 million in Q1 2026 from $6.7 million in Q1 2025.
- Diluted earnings per share (EPS) increased to $0.29 in Q1 2026, compared to $0.14 in Q1 2025.
- Net cash provided by operating activities surged 309.3% to $68.1 million for Q1 2026.
- Capitation revenue, net, grew to $892.9 million in Q1 2026 from $584.0 million in Q1 2025.
- Medicare revenue increased to $608.1 million in Q1 2026 from $389.4 million in Q1 2025.
- Total assets as of March 31, 2026, were $2.36 billion, up from $2.22 billion at December 31, 2025.
- Cash and cash equivalents increased to $478.4 million as of March 31, 2026, from $429.5 million.
Price Impact
More from ASTH